Toronto Dominion Bank
RYTM icon

Toronto Dominion Bank’s Rhythm Pharmaceuticals RYTM Stock Holding History

Toronto Dominion Bank’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6
Closed -$522 – 2443
2026
Q1 		$522 Hold
6
– – ﹤0.01% 2038
2025
Q4 		$642 Buy
+6
New +$636 ﹤0.01% 1954
2022
Q2 		– Sell
-335
Closed -$4K – 1793
2022
Q1 		$4K Buy
+335
New +$2.94K ﹤0.01% 1290

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Toronto Dominion Bank's RYTM Position: Q2 2026 in Review

Toronto Dominion Bank sold out of Rhythm Pharmaceuticals (RYTM) in Q2 2026, closing a stake of 6 shares — an estimated $522 sold.

Toronto Dominion Bank first reported a position in RYTM in Q1 2022 and held it in 3 quarters. The position peaked at $4K in Q1 2022. 305 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Toronto Dominion Bank reported no remaining Rhythm Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Toronto Dominion Bank sold 6 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $522.
  • Toronto Dominion Bank first reported a position in Rhythm Pharmaceuticals in Q1 2022 and held it in 3 quarters.
  • Toronto Dominion Bank's Rhythm Pharmaceuticals position peaked at $4K in Q1 2022.
  • 305 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.